Skip to Content
Webinar Recording

Addressing the Unmet Need in Gastric and Gastroesophageal Junction (GEJ) Cancer with Zolbetuximab-clzb

Recorded on: November 19, 2024

Explore the latest advancements in treating gastric and gastroesophageal junction (GEJ) cancers, with a focus on zolbetuximab-clzb. Gain insights into its safety profile, common side effects, and essential strategies for patient education and support to ensure effective therapy initiation.

Presenters:
John L Marshall, MD | Lombardi Comprehensive Cancer Center | Georgetown University Medical Center
Reetu Mukherji, MD | MedStar Georgetown University Hospital | Lombardi Comprehensive Cancer Center | Georgetown University Medical Center